0000000001103203

AUTHOR

Cristian Falup-pecurariu

showing 2 related works from this author

Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia.

2020

BACKGROUND: Little information is available on the official postgraduate and subspecialty training programs in movement disorders (MD) in Europe and North Africa.OBJECTIVE: To survey the accessible MD clinical training in these regions.METHODS: We designed a survey on clinical training in MD in different medical fields, at postgraduate and specialized levels. We assessed the characteristics of the participants and the facilities for MD care in their respective countries. We examined whether there are structured, or even accredited postgraduate, or subspecialty MD training programs in neurology, neurosurgery, internal medicine, geriatrics, neuroradiology, neuropediatrics, and general practic…

medicine.medical_specialtyMovement disordersTunisiaParkinson's diseaseeducationNorth africaCertificationSubspecialtyDIAGNOSIS3124 Neurology and psychiatryAccreditation03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineHumans030212 general & internal medicineCurriculumAccreditationGeriatricsMedical educationeducationMovement Disorders4. Education3112 Neurosciences3. Good healthEuropeNeurologyEducation Medical GraduateClinical trainingHealth Care SurveysSUBSPECIALIZATIONEgyptNeurology (clinical)Curriculummedicine.symptomPsychology030217 neurology & neurosurgeryJournal of Parkinson's disease
researchProduct

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

2022

[Background and Purpose] Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year.

StrokeVaccine-induced immune thrombotic thrombocytopeniaSDG 3 - Good Health and Well-beingCerebral venous thrombosisSARS-CoV-23112 NeurosciencesCOVID-19COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; StrokeNeurology (clinical)MortalityCardiology and Cardiovascular Medicine3124 Neurology and psychiatryCOVID-19; Cerebral venous thrombosis; Mortality; SARS-CoV-2; Stroke; Vaccine-induced immune thrombotic thrombocytopeniaJournal of Stroke
researchProduct